Krsnaa Diagnostics schedules Q1 FY27 earnings call for Aug 14, 2026
Krsnaa Diagnostics Limited will hold its Q1 FY27 earnings conference call on August 14, 2026, at 13:00 IST. Management will discuss financial results for the quarter ended June 30, 2026.
This is a routine disclosure about a scheduled conference call to discuss past financial results. It does not involve any new material event or information that would significantly impact the company's stock or operations.
The announcement is a routine disclosure regarding a scheduled conference call to discuss financial results. It does not contain any new financial information or strategic updates that would indicate a positive or negative sentiment.
Krsnaa Diagnostics Limited has announced that its post-earnings conference call is scheduled for Friday, August 14, 2026, at 13:00 IST.
The call will feature a discussion by the management on the company's financial results for the quarter ended June 30, 2026, followed by an interactive Question and Answer session.
Equirus Securities Private Limited is hosting the Q1 FY27 Earnings Conference Call for Krsnaa Diagnostics Ltd. The call will include speakers such as Mr. Rajendra Mutha (Chairman & Whole-time Director), Mr. Yash Mutha (Managing Director), Mr. Mitesh Dave (Group CEO), Mr. Chandra Prakash Singh (Interim Chief Financial Officer), and Mr. Sujoy Bose (Head - Secretarial, Legal and Compliance). The call leader will be Bharat Celly from Equirus Securities.
Details for joining the call, including a DiamondPass registration link and various international dial-in numbers, have been provided. The transcript and audio recording of the conference call will be made available on the company's website, www.krsnaadiagnostics.com/investors, subsequently.
What to do with a filing like this
Krsnaa Diagnostics Limited filed this with the NSE as a statutory disclosure, categorised under concall scheduled. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Krsnaa Diagnostics Limited. Read the original for the full detail.